Replies to post #100878 on Biotech Values

[DewDiligence]

In other words, you believe there might not be another leg down if a TEVA generic is approved?

Perhaps, but I don’t think such a drop would be unduly large. More important, the probability of such an outcome has not increased, IMO, just because Bernstein says it has.